Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2016)

Viridian Therapeutics, Inc.\DE (VRDN) has 3 years of Change in Inventory data on record, last reported at $2000.0 in Q4 2016.

  • For Q4 2016, Change in Inventory rose 101.13% year-over-year to $2000.0; the TTM value through Dec 2016 reached -$123000.0, down 1637.5%, while the annual FY2016 figure was -$123000.0, 1637.5% down from the prior year.
  • Change in Inventory reached $2000.0 in Q4 2016 per VRDN's latest filing, up from -$151000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $206000.0 in Q2 2015 and bottomed at -$232000.0 in Q1 2014.
  • Average Change in Inventory over 3 years is -$24416.7, with a median of -$25500.0 recorded in 2014.
  • The widest YoY moves for Change in Inventory: up 202.94% in 2015, down 541.03% in 2015.
  • A 3-year view of Change in Inventory shows it stood at -$53000.0 in 2014, then plummeted by 233.96% to -$177000.0 in 2015, then skyrocketed by 101.13% to $2000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $2000.0 in Q4 2016, -$151000.0 in Q3 2016, and -$56000.0 in Q2 2016.